Abstract
A two-dimensional photonic crystal defect waveguide sensor based on CMOS-compatible silicon-on-insulator technology was designed for operation in aqueous solutions at a wavelength of 1.34 µm, by the use of the 3D Plane Wave Expansion and the Finite Difference Time Domain simulation method. An operation under water in this wavelength regime allows for a significantly smaller propagation loss in contrast to the state-of-the-art operation wavelength of photonic crystals at 1.55 µm. The sensor working principle is label-free and based on evanescent wave sensing exploiting the local refractive index change induced by the specific binding of target molecules to a capture molecules immobilized on the surface of the phontonic crystal structure. We experimentally proved the theoretical predications of our simulations and demonstrated the sensing functionality of the photonic crystal defect waveguide using the biotin-straptavidin binding system.
Highlights
The label-free detection of biomolecules in liquid samples is a highly desirable feature in a wide range of applications such as medical and pharmaceutical research, molecular diagnostics, environment monitoring, as well as process and quality control in food industry
All these concepts exploit the effective refractive index change of the guided optical wave that is induced by the specific binding of target molecules to a thin biochemical functionalization layer on top of the waveguide surface
We report the design of a 2D silicon photonic crystal (PhC) defect waveguide operating at 1.34 μm and demonstrate its suitability for biosensing by observing the binding of single and multi-layer biotin-streptavidin biofilms
Summary
The label-free detection of biomolecules in liquid samples is a highly desirable feature in a wide range of applications such as medical and pharmaceutical research, molecular diagnostics, environment monitoring, as well as process and quality control in food industry. During the last decades various integrated optical waveguide concepts have been intensively investigated as a promising means to realize sensitive label-free biomolecule detection [1]. All these concepts exploit the effective refractive index change of the guided optical wave that is induced by the specific binding of target molecules to a thin biochemical functionalization layer on top of the waveguide surface. With respect to the choice of operation wavelength, propagation loss represents a very important issue because it directly impacts the overall sensing performance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.